skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Species differences in impairment and recovery of alveolar macrophage functions following single and repeated ozone exposures

Journal Article · · Toxicology and Applied Pharmacology; (United States)
; ; ;  [1]
  1. Laboratory for Toxicology, National Institute of Public Health and Environmental Protection, Bilthoven, (Netherlands)

Effects of single (0.4 ppm for 3, 6, or 12 hr) and repeated (0.4 ppm, 12 hr/day for 3 or 7 days) in vivo ozone exposures on rat and mouse alveolar macrophage functions and cell number were investigated. Single ozone exposure of rats resulted in a small (approximately 15%) decrease in Fc-receptor-mediated phagocytosis and phorbol ester-induced superoxide production by the alveolar macrophages and was followed by recovery above control levels within 12 hr of exposure. Repeated exposures of rats for up to 7 days did not alter alveolar macrophage functions, with the exception of the effects of 3 days of exposure on superoxide production (71 {plus minus} 9% as compared with the controls). In mice, significant changes in alveolar macrophage functions were not observed until 12 hr of exposure (at that timepoint phagocytosis was 74 {plus minus} 2%). Repeated ozone exposures of mice did not cause a further decrease in phagocytosis (at Day 7, 74 {plus minus} 14%). Both after 3 and 7 days of repeated ozone exposure of mice, superoxide production by the alveolar macrophages was inhibited approximately 50%. In rats and mice, repeated ozone exposures led to an increase in the number of alveolar macrophages. In mice, this increase appeared at a later time point (at Day 7 vs Day 3) and was less pronounced (at Day 7, 139 {plus minus} 9% vs 179 {plus minus} 17%) as compared with rats. In summary, our data show that rat and mouse alveolar macrophages have different susceptibilities to both single and repeated in vivo ozone exposures.

OSTI ID:
5226774
Journal Information:
Toxicology and Applied Pharmacology; (United States), Vol. 110:1; ISSN 0041-008X
Country of Publication:
United States
Language:
English